| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinitis Pigmentosa | 77 | 2010 | 395 | 7.960 |
Why?
|
| Eye Proteins | 37 | 2008 | 628 | 3.930 |
Why?
|
| Retinoblastoma | 41 | 2020 | 321 | 2.780 |
Why?
|
| Rhodopsin | 30 | 2009 | 202 | 2.480 |
Why?
|
| Retinal Degeneration | 17 | 2019 | 414 | 1.930 |
Why?
|
| Genes, Recessive | 27 | 2008 | 625 | 1.790 |
Why?
|
| Macular Degeneration | 13 | 2023 | 1015 | 1.700 |
Why?
|
| Night Blindness | 13 | 2008 | 58 | 1.580 |
Why?
|
| Mutation, Missense | 18 | 2010 | 2592 | 1.520 |
Why?
|
| Genes, Dominant | 23 | 2009 | 855 | 1.510 |
Why?
|
| Uveal Neoplasms | 6 | 2021 | 344 | 1.410 |
Why?
|
| Photoreceptor Cells, Vertebrate | 11 | 2009 | 203 | 1.400 |
Why?
|
| Pedigree | 71 | 2008 | 4539 | 1.370 |
Why?
|
| Electroretinography | 39 | 2009 | 524 | 1.350 |
Why?
|
| Point Mutation | 22 | 2005 | 1594 | 1.310 |
Why?
|
| Eye Neoplasms | 27 | 2007 | 306 | 1.170 |
Why?
|
| Choroidal Neovascularization | 6 | 2016 | 364 | 1.140 |
Why?
|
| Mutation | 65 | 2010 | 30211 | 1.060 |
Why?
|
| Retinal Neoplasms | 6 | 2020 | 151 | 1.060 |
Why?
|
| Retinal Rod Photoreceptor Cells | 10 | 2008 | 204 | 0.930 |
Why?
|
| Genes, Retinoblastoma | 12 | 2001 | 125 | 0.910 |
Why?
|
| DNA Mutational Analysis | 29 | 2006 | 4114 | 0.880 |
Why?
|
| Chromosomes, Human, Pair 13 | 12 | 1999 | 192 | 0.870 |
Why?
|
| Retinal Diseases | 10 | 2017 | 710 | 0.860 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 7 | 1999 | 56 | 0.860 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 4 | 2007 | 50 | 0.850 |
Why?
|
| Blindness | 9 | 2008 | 587 | 0.840 |
Why?
|
| Eye Diseases, Hereditary | 4 | 2005 | 124 | 0.820 |
Why?
|
| Ciliary Body | 4 | 2021 | 168 | 0.780 |
Why?
|
| Retina | 18 | 2023 | 2662 | 0.750 |
Why?
|
| Frameshift Mutation | 5 | 2007 | 392 | 0.720 |
Why?
|
| Extracellular Matrix Proteins | 6 | 2010 | 832 | 0.700 |
Why?
|
| Complement System Proteins | 2 | 2021 | 738 | 0.680 |
Why?
|
| Molecular Biology | 3 | 2020 | 573 | 0.670 |
Why?
|
| Mixed Tumor, Mullerian | 1 | 2019 | 55 | 0.670 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 17 | 2003 | 325 | 0.670 |
Why?
|
| Molecular Sequence Data | 56 | 2006 | 17617 | 0.660 |
Why?
|
| Base Sequence | 48 | 2017 | 12418 | 0.660 |
Why?
|
| Retinal Cone Photoreceptor Cells | 6 | 2008 | 183 | 0.660 |
Why?
|
| Pigment Epithelium of Eye | 10 | 2021 | 209 | 0.630 |
Why?
|
| Eye Infections | 1 | 2019 | 63 | 0.630 |
Why?
|
| Alleles | 26 | 2017 | 6894 | 0.630 |
Why?
|
| Cytogenetics | 1 | 2019 | 198 | 0.630 |
Why?
|
| Cytogenetic Analysis | 1 | 2019 | 270 | 0.610 |
Why?
|
| Genetic Linkage | 14 | 2001 | 2342 | 0.590 |
Why?
|
| Heterozygote | 16 | 2017 | 2798 | 0.590 |
Why?
|
| Retinal Pigment Epithelium | 3 | 2023 | 309 | 0.560 |
Why?
|
| Chromosomes, Human, Pair 10 | 2 | 2017 | 275 | 0.550 |
Why?
|
| Orbital Neoplasms | 1 | 2019 | 223 | 0.550 |
Why?
|
| Visual Acuity | 22 | 2008 | 2714 | 0.540 |
Why?
|
| Polymorphism, Restriction Fragment Length | 16 | 1993 | 766 | 0.530 |
Why?
|
| Rhabdomyosarcoma | 1 | 2019 | 358 | 0.520 |
Why?
|
| Sequence Analysis, DNA | 12 | 2019 | 4785 | 0.520 |
Why?
|
| Fundus Oculi | 13 | 2014 | 560 | 0.490 |
Why?
|
| Haplotypes | 3 | 2017 | 2722 | 0.490 |
Why?
|
| Photoreceptor Cells | 9 | 1998 | 234 | 0.480 |
Why?
|
| Optic Atrophies, Hereditary | 3 | 2001 | 27 | 0.480 |
Why?
|
| Chromosomes, Human, 13-15 | 12 | 1988 | 49 | 0.480 |
Why?
|
| Amino Acid Sequence | 36 | 2005 | 13420 | 0.470 |
Why?
|
| Transducin | 7 | 2005 | 42 | 0.470 |
Why?
|
| Codon, Nonsense | 2 | 2006 | 287 | 0.450 |
Why?
|
| Rod Cell Outer Segment | 5 | 1997 | 50 | 0.440 |
Why?
|
| Alcohol Oxidoreductases | 3 | 2008 | 164 | 0.440 |
Why?
|
| Dark Adaptation | 15 | 2008 | 224 | 0.440 |
Why?
|
| Retinaldehyde | 4 | 2004 | 24 | 0.430 |
Why?
|
| Deafness | 4 | 2001 | 460 | 0.420 |
Why?
|
| Proline | 6 | 2000 | 455 | 0.420 |
Why?
|
| DNA Primers | 15 | 2008 | 2827 | 0.410 |
Why?
|
| Polymerase Chain Reaction | 22 | 2019 | 6071 | 0.400 |
Why?
|
| DNA | 25 | 2002 | 7213 | 0.400 |
Why?
|
| Laser Coagulation | 1 | 2014 | 334 | 0.400 |
Why?
|
| Visual Fields | 17 | 2018 | 1065 | 0.390 |
Why?
|
| Protein Kinases | 4 | 2004 | 1610 | 0.390 |
Why?
|
| Neoplasm Proteins | 2 | 2021 | 3601 | 0.390 |
Why?
|
| Interleukin-17 | 2 | 2015 | 924 | 0.390 |
Why?
|
| Rod Opsins | 7 | 1999 | 108 | 0.390 |
Why?
|
| Chromosome Mapping | 24 | 2007 | 4618 | 0.380 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2040 | 0.370 |
Why?
|
| Polymorphism, Genetic | 20 | 2006 | 4248 | 0.370 |
Why?
|
| Retinal Pigments | 4 | 2008 | 84 | 0.370 |
Why?
|
| Dry Eye Syndromes | 1 | 2015 | 385 | 0.360 |
Why?
|
| Intermediate Filament Proteins | 4 | 1997 | 261 | 0.360 |
Why?
|
| Membrane Proteins | 9 | 2017 | 7876 | 0.360 |
Why?
|
| Physician Executives | 1 | 2012 | 140 | 0.360 |
Why?
|
| Uterine Neoplasms | 1 | 2019 | 1424 | 0.360 |
Why?
|
| Eyelid Neoplasms | 3 | 2018 | 88 | 0.350 |
Why?
|
| Exons | 17 | 2008 | 2393 | 0.350 |
Why?
|
| Carrier Proteins | 6 | 2004 | 4937 | 0.340 |
Why?
|
| Rare Diseases | 2 | 2005 | 631 | 0.340 |
Why?
|
| Homozygote | 8 | 2017 | 1778 | 0.340 |
Why?
|
| Paraneoplastic Syndromes | 2 | 2002 | 154 | 0.340 |
Why?
|
| Eye Diseases | 5 | 2006 | 660 | 0.340 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 1027 | 0.330 |
Why?
|
| Genetic Counseling | 4 | 2020 | 635 | 0.330 |
Why?
|
| Chromosome Deletion | 12 | 1996 | 1384 | 0.330 |
Why?
|
| Genetic Heterogeneity | 4 | 2004 | 736 | 0.330 |
Why?
|
| Humans | 208 | 2023 | 767991 | 0.320 |
Why?
|
| IMP Dehydrogenase | 2 | 2005 | 34 | 0.310 |
Why?
|
| Adenocarcinoma | 7 | 2021 | 6371 | 0.300 |
Why?
|
| Female | 121 | 2023 | 397113 | 0.290 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 1999 | 350 | 0.290 |
Why?
|
| Codon | 10 | 1999 | 599 | 0.280 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2006 | 35 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2002 | 640 | 0.280 |
Why?
|
| Potassium Channels, Voltage-Gated | 1 | 2007 | 142 | 0.270 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3669 | 0.270 |
Why?
|
| Male | 108 | 2023 | 364641 | 0.270 |
Why?
|
| X Chromosome | 4 | 2000 | 819 | 0.270 |
Why?
|
| Ion Channels | 2 | 2005 | 1044 | 0.260 |
Why?
|
| Uniparental Disomy | 2 | 2002 | 46 | 0.260 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2021 | 3187 | 0.250 |
Why?
|
| Acyltransferases | 1 | 2007 | 306 | 0.240 |
Why?
|
| Ophthalmology | 1 | 2012 | 560 | 0.240 |
Why?
|
| Introns | 7 | 2006 | 966 | 0.240 |
Why?
|
| Color Vision Defects | 1 | 2005 | 28 | 0.240 |
Why?
|
| Arrestin | 4 | 1998 | 30 | 0.240 |
Why?
|
| Spinocerebellar Ataxias | 2 | 2005 | 108 | 0.240 |
Why?
|
| Uveal Diseases | 3 | 2002 | 45 | 0.240 |
Why?
|
| Nerve Tissue Proteins | 6 | 2002 | 4414 | 0.230 |
Why?
|
| Proteins | 4 | 2017 | 6009 | 0.230 |
Why?
|
| Syndrome | 7 | 2005 | 3271 | 0.230 |
Why?
|
| Corneal Dystrophies, Hereditary | 2 | 2005 | 62 | 0.230 |
Why?
|
| Melanoma | 6 | 2020 | 5706 | 0.230 |
Why?
|
| Vision, Ocular | 3 | 2008 | 458 | 0.230 |
Why?
|
| Homeodomain Proteins | 3 | 2002 | 2429 | 0.230 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 4282 | 0.220 |
Why?
|
| Trans-Activators | 3 | 2002 | 2857 | 0.220 |
Why?
|
| RGS Proteins | 1 | 2004 | 76 | 0.220 |
Why?
|
| Melanocytes | 4 | 2002 | 509 | 0.220 |
Why?
|
| Phosphoproteins | 4 | 2004 | 2450 | 0.220 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2005 | 196 | 0.210 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2004 | 77 | 0.210 |
Why?
|
| Oncogenes | 7 | 1990 | 1232 | 0.210 |
Why?
|
| Telomere | 1 | 2009 | 943 | 0.210 |
Why?
|
| Optic Disk Drusen | 1 | 2023 | 38 | 0.200 |
Why?
|
| Gene Frequency | 5 | 2008 | 3623 | 0.200 |
Why?
|
| Carboxylesterase | 5 | 1986 | 31 | 0.200 |
Why?
|
| Leadership | 1 | 2012 | 1397 | 0.200 |
Why?
|
| Adult | 64 | 2021 | 223583 | 0.200 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2002 | 90 | 0.200 |
Why?
|
| Glaucoma, Open-Angle | 2 | 2019 | 742 | 0.190 |
Why?
|
| Endometrial Neoplasms | 2 | 2002 | 1382 | 0.190 |
Why?
|
| Complement Pathway, Alternative | 2 | 2021 | 113 | 0.190 |
Why?
|
| Adaptation, Ocular | 2 | 1999 | 89 | 0.190 |
Why?
|
| Keratoconus | 1 | 2023 | 112 | 0.190 |
Why?
|
| Cloning, Molecular | 14 | 2019 | 4168 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 2 | 2015 | 9252 | 0.180 |
Why?
|
| Apolipoproteins E | 1 | 2007 | 1461 | 0.180 |
Why?
|
| Macula Lutea | 1 | 2001 | 180 | 0.170 |
Why?
|
| Vision Disorders | 2 | 2007 | 1093 | 0.170 |
Why?
|
| Gelsolin | 1 | 2001 | 189 | 0.170 |
Why?
|
| Genetic Testing | 6 | 2020 | 3589 | 0.170 |
Why?
|
| Choroid | 3 | 2021 | 364 | 0.170 |
Why?
|
| Vitreous Body | 3 | 1999 | 401 | 0.170 |
Why?
|
| Isoenzymes | 3 | 1999 | 1688 | 0.170 |
Why?
|
| Retinol-Binding Proteins | 2 | 2008 | 67 | 0.170 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 11930 | 0.170 |
Why?
|
| Penetrance | 2 | 1999 | 385 | 0.160 |
Why?
|
| Middle Aged | 52 | 2021 | 223422 | 0.160 |
Why?
|
| Complement Activation | 1 | 2021 | 447 | 0.160 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2019 | 101 | 0.160 |
Why?
|
| Corneal Transplantation | 1 | 2023 | 315 | 0.160 |
Why?
|
| Germ-Line Mutation | 2 | 1998 | 1883 | 0.160 |
Why?
|
| Gene Expression | 8 | 2006 | 7597 | 0.160 |
Why?
|
| Complement Factor H | 3 | 2008 | 110 | 0.160 |
Why?
|
| Calcium Channel Blockers | 2 | 2019 | 688 | 0.160 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2003 | 861 | 0.160 |
Why?
|
| Myosins | 1 | 2000 | 408 | 0.160 |
Why?
|
| Hidrocystoma | 1 | 2018 | 10 | 0.150 |
Why?
|
| Carboxylic Ester Hydrolases | 5 | 1986 | 99 | 0.150 |
Why?
|
| Ophthalmoplegia | 1 | 2019 | 168 | 0.150 |
Why?
|
| DNA-Binding Proteins | 5 | 2004 | 9614 | 0.150 |
Why?
|
| Amino Acid Substitution | 4 | 2007 | 1743 | 0.150 |
Why?
|
| Complement Factor D | 1 | 2018 | 67 | 0.150 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2017 | 18062 | 0.150 |
Why?
|
| Diagnosis, Differential | 7 | 2020 | 13000 | 0.150 |
Why?
|
| Iris | 7 | 1982 | 232 | 0.150 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2001 | 567 | 0.150 |
Why?
|
| Ataxia | 1 | 2000 | 307 | 0.150 |
Why?
|
| DNA, Ribosomal | 1 | 2019 | 300 | 0.150 |
Why?
|
| DNA, Fungal | 1 | 2019 | 275 | 0.150 |
Why?
|
| Hyaluronic Acid | 2 | 2018 | 484 | 0.150 |
Why?
|
| Linkage Disequilibrium | 4 | 2017 | 1997 | 0.140 |
Why?
|
| Epidermal Cyst | 1 | 2018 | 63 | 0.140 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1999 | 411 | 0.140 |
Why?
|
| Vestibular Diseases | 1 | 2000 | 232 | 0.140 |
Why?
|
| Sweat Gland Neoplasms | 2 | 2018 | 111 | 0.140 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2002 | 489 | 0.140 |
Why?
|
| Laurence-Moon Syndrome | 1 | 1997 | 9 | 0.140 |
Why?
|
| Prolactinoma | 1 | 2018 | 114 | 0.140 |
Why?
|
| Osteosarcoma | 4 | 1989 | 911 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 2 | 2004 | 1083 | 0.140 |
Why?
|
| Fatal Outcome | 4 | 2002 | 1836 | 0.140 |
Why?
|
| Genotype | 9 | 2008 | 13042 | 0.140 |
Why?
|
| Trabecular Meshwork | 1 | 2017 | 101 | 0.140 |
Why?
|
| Restriction Mapping | 6 | 1994 | 849 | 0.140 |
Why?
|
| Aqueous Humor | 1 | 2017 | 152 | 0.140 |
Why?
|
| Loss of Heterozygosity | 1 | 1999 | 663 | 0.130 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 6 | 4 | 1999 | 27 | 0.130 |
Why?
|
| Sex Chromosome Aberrations | 1 | 1996 | 116 | 0.130 |
Why?
|
| Orbit | 1 | 2019 | 459 | 0.130 |
Why?
|
| Cosmetic Techniques | 1 | 2018 | 149 | 0.130 |
Why?
|
| Membrane Glycoproteins | 4 | 1997 | 3710 | 0.130 |
Why?
|
| Protein Structure, Secondary | 2 | 1997 | 1216 | 0.130 |
Why?
|
| Amyloid Neuropathies | 1 | 1995 | 15 | 0.130 |
Why?
|
| Recombination, Genetic | 4 | 1999 | 1525 | 0.130 |
Why?
|
| Microsatellite Repeats | 4 | 2007 | 784 | 0.130 |
Why?
|
| Fluorescein Angiography | 5 | 2014 | 1086 | 0.130 |
Why?
|
| Lymphoma, B-Cell | 1 | 2002 | 945 | 0.130 |
Why?
|
| Oculomotor Muscles | 1 | 2019 | 405 | 0.130 |
Why?
|
| Aged | 35 | 2021 | 171446 | 0.120 |
Why?
|
| Adolescent | 28 | 2015 | 89155 | 0.120 |
Why?
|
| Gene Deletion | 2 | 2001 | 2673 | 0.120 |
Why?
|
| Cattle | 10 | 2017 | 3819 | 0.120 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2019 | 1059 | 0.120 |
Why?
|
| Valine | 2 | 2000 | 410 | 0.120 |
Why?
|
| RNA, Messenger | 7 | 2021 | 12797 | 0.120 |
Why?
|
| Genetics, Medical | 1 | 1997 | 334 | 0.120 |
Why?
|
| Protein Kinase C | 1 | 1999 | 1207 | 0.120 |
Why?
|
| Mosaicism | 1 | 1998 | 480 | 0.120 |
Why?
|
| Intraocular Pressure | 2 | 2018 | 1304 | 0.120 |
Why?
|
| Wet Macular Degeneration | 1 | 2016 | 165 | 0.120 |
Why?
|
| Transcription Factors | 3 | 2017 | 12165 | 0.110 |
Why?
|
| DNA, Bacterial | 1 | 2019 | 1478 | 0.110 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1991 | 1057 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 6 | 2008 | 5798 | 0.110 |
Why?
|
| Tears | 1 | 2015 | 254 | 0.110 |
Why?
|
| Testis | 1 | 2017 | 783 | 0.110 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2017 | 662 | 0.110 |
Why?
|
| Prealbumin | 1 | 1995 | 259 | 0.110 |
Why?
|
| Injections, Intravenous | 1 | 2015 | 1377 | 0.110 |
Why?
|
| Retinal Detachment | 3 | 2006 | 429 | 0.110 |
Why?
|
| G-Protein-Coupled Receptor Kinase 1 | 3 | 1997 | 7 | 0.110 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2017 | 2889 | 0.110 |
Why?
|
| Genetic Markers | 6 | 1997 | 2602 | 0.110 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 2 | 2004 | 153 | 0.100 |
Why?
|
| Transforming Growth Factor beta | 1 | 2001 | 1996 | 0.100 |
Why?
|
| Histidine | 2 | 2008 | 301 | 0.100 |
Why?
|
| Serine | 1 | 1996 | 831 | 0.100 |
Why?
|
| Immunohistochemistry | 3 | 2021 | 11068 | 0.100 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1997 | 606 | 0.100 |
Why?
|
| Child | 23 | 2008 | 80906 | 0.100 |
Why?
|
| Ovary | 1 | 2017 | 965 | 0.100 |
Why?
|
| Drugs, Generic | 1 | 2018 | 455 | 0.100 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3813 | 0.100 |
Why?
|
| Chromosomes, Human, X | 2 | 2005 | 320 | 0.100 |
Why?
|
| Perfusion | 1 | 2017 | 1401 | 0.100 |
Why?
|
| Aged, 80 and over | 16 | 2019 | 59598 | 0.100 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 1993 | 205 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 1999 | 1247 | 0.100 |
Why?
|
| Lipoproteins | 1 | 1997 | 879 | 0.100 |
Why?
|
| Amyloidosis | 1 | 2019 | 878 | 0.100 |
Why?
|
| Smoking | 3 | 2007 | 9089 | 0.090 |
Why?
|
| Genetic Diseases, X-Linked | 2 | 2007 | 386 | 0.090 |
Why?
|
| Binding Sites | 3 | 2017 | 6022 | 0.090 |
Why?
|
| Models, Animal | 1 | 2018 | 2120 | 0.090 |
Why?
|
| Darkness | 4 | 1995 | 159 | 0.090 |
Why?
|
| Animals | 34 | 2023 | 169222 | 0.090 |
Why?
|
| Nevus, Pigmented | 2 | 2006 | 222 | 0.090 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 2 | 2005 | 39 | 0.090 |
Why?
|
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 | 2002 | 1642 | 0.090 |
Why?
|
| Sp1 Transcription Factor | 1 | 1991 | 143 | 0.090 |
Why?
|
| Autoantibodies | 1 | 2019 | 2117 | 0.090 |
Why?
|
| Complement Factor B | 2 | 2023 | 57 | 0.090 |
Why?
|
| Prescription Drugs | 1 | 2018 | 635 | 0.090 |
Why?
|
| Amyloid | 1 | 1995 | 854 | 0.090 |
Why?
|
| DNA, Neoplasm | 6 | 1991 | 1742 | 0.090 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2819 | 0.090 |
Why?
|
| Lacrimal Apparatus | 1 | 1992 | 224 | 0.090 |
Why?
|
| Collagen | 1 | 2018 | 2641 | 0.090 |
Why?
|
| Vitamin A | 2 | 2006 | 611 | 0.090 |
Why?
|
| Mice | 21 | 2023 | 82024 | 0.090 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2019 | 1901 | 0.090 |
Why?
|
| Phenotype | 9 | 2005 | 16723 | 0.080 |
Why?
|
| Monophenol Monooxygenase | 3 | 1984 | 72 | 0.080 |
Why?
|
| Usher Syndromes | 1 | 2010 | 56 | 0.080 |
Why?
|
| Catechol Oxidase | 2 | 1980 | 3 | 0.080 |
Why?
|
| Hybrid Cells | 6 | 1996 | 421 | 0.080 |
Why?
|
| Leucine | 1 | 1991 | 547 | 0.080 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 8052 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2017 | 18344 | 0.080 |
Why?
|
| Pituitary Neoplasms | 1 | 2018 | 1322 | 0.080 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2008 | 4576 | 0.080 |
Why?
|
| Blotting, Southern | 6 | 1997 | 775 | 0.080 |
Why?
|
| Methionine | 2 | 1991 | 573 | 0.080 |
Why?
|
| Antigens | 2 | 1995 | 1442 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2017 | 16041 | 0.080 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2005 | 2748 | 0.080 |
Why?
|
| Cell Line | 10 | 2006 | 15597 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2017 | 3740 | 0.080 |
Why?
|
| Glaucoma | 2 | 2017 | 1194 | 0.080 |
Why?
|
| Microtubule-Associated Proteins | 2 | 2005 | 1074 | 0.070 |
Why?
|
| 3' Untranslated Regions | 2 | 2008 | 515 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 1 | 2018 | 2011 | 0.070 |
Why?
|
| Chromosomes, Human, 1-3 | 2 | 1986 | 21 | 0.070 |
Why?
|
| Retinoblastoma Protein | 5 | 1999 | 671 | 0.070 |
Why?
|
| Citric Acid Cycle | 1 | 2008 | 234 | 0.070 |
Why?
|
| Retinitis | 1 | 2007 | 36 | 0.070 |
Why?
|
| Lod Score | 4 | 1997 | 600 | 0.070 |
Why?
|
| DNA Probes | 3 | 1994 | 542 | 0.070 |
Why?
|
| Scleral Diseases | 1 | 2007 | 22 | 0.070 |
Why?
|
| Uveitis | 1 | 2010 | 398 | 0.070 |
Why?
|
| Myofibroma | 1 | 2007 | 45 | 0.070 |
Why?
|
| Choroid Neoplasms | 3 | 2003 | 177 | 0.070 |
Why?
|
| DNA Restriction Enzymes | 6 | 1986 | 548 | 0.070 |
Why?
|
| Chromosome Aberrations | 2 | 1991 | 1777 | 0.070 |
Why?
|
| Light | 3 | 2004 | 1358 | 0.070 |
Why?
|
| DNA, Complementary | 2 | 2002 | 1989 | 0.070 |
Why?
|
| Sequence Alignment | 3 | 2005 | 2178 | 0.070 |
Why?
|
| Hearing Loss | 2 | 2004 | 785 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 3 | 1993 | 705 | 0.060 |
Why?
|
| Blood Proteins | 1 | 1991 | 1191 | 0.060 |
Why?
|
| Phosphenes | 1 | 2006 | 41 | 0.060 |
Why?
|
| Tyrosine | 2 | 2008 | 1427 | 0.060 |
Why?
|
| Retrospective Studies | 9 | 2023 | 81746 | 0.060 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2006 | 45 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2006 | 3798 | 0.060 |
Why?
|
| Conjunctival Diseases | 1 | 2006 | 109 | 0.060 |
Why?
|
| Photic Stimulation | 3 | 2008 | 1998 | 0.060 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 1995 | 781 | 0.060 |
Why?
|
| Cornea | 2 | 2023 | 1316 | 0.060 |
Why?
|
| Intravitreal Injections | 2 | 2018 | 402 | 0.060 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 3 | 1990 | 167 | 0.060 |
Why?
|
| Cytoskeletal Proteins | 2 | 2001 | 1327 | 0.060 |
Why?
|
| Mitochondrial Encephalomyopathies | 1 | 2005 | 40 | 0.060 |
Why?
|
| Siblings | 2 | 2007 | 828 | 0.060 |
Why?
|
| Pyridines | 1 | 2017 | 2893 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1985 | 1305 | 0.060 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2005 | 94 | 0.060 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 5861 | 0.060 |
Why?
|
| Molecular Epidemiology | 1 | 2007 | 473 | 0.060 |
Why?
|
| Disease Progression | 3 | 2019 | 13665 | 0.060 |
Why?
|
| Consensus Sequence | 1 | 2005 | 363 | 0.060 |
Why?
|
| NAD | 1 | 2008 | 618 | 0.060 |
Why?
|
| GTP-Binding Protein Regulators | 1 | 2004 | 12 | 0.060 |
Why?
|
| Microscopy, Electron | 4 | 1998 | 2559 | 0.060 |
Why?
|
| Granuloma | 1 | 2006 | 329 | 0.060 |
Why?
|
| Eye | 2 | 1979 | 712 | 0.060 |
Why?
|
| DNA, Satellite | 2 | 1994 | 67 | 0.060 |
Why?
|
| Transfection | 5 | 2002 | 5757 | 0.060 |
Why?
|
| Sound | 1 | 2006 | 261 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2004 | 206 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 1998 | 370 | 0.060 |
Why?
|
| Double-Blind Method | 2 | 2015 | 12464 | 0.060 |
Why?
|
| Models, Structural | 2 | 1995 | 340 | 0.050 |
Why?
|
| Hyperopia | 1 | 2003 | 41 | 0.050 |
Why?
|
| Refractive Errors | 1 | 2005 | 148 | 0.050 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2014 | 3514 | 0.050 |
Why?
|
| Chromosome Banding | 4 | 1995 | 261 | 0.050 |
Why?
|
| Osteoma | 1 | 2003 | 12 | 0.050 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2003 | 63 | 0.050 |
Why?
|
| Contrast Sensitivity | 1 | 2005 | 253 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2018 | 22381 | 0.050 |
Why?
|
| Rabbits | 3 | 2018 | 4771 | 0.050 |
Why?
|
| Hallucinations | 1 | 2006 | 373 | 0.050 |
Why?
|
| Temporal Arteries | 1 | 2004 | 155 | 0.050 |
Why?
|
| Open Reading Frames | 2 | 2003 | 818 | 0.050 |
Why?
|
| Dolphins | 1 | 2002 | 14 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2005 | 423 | 0.050 |
Why?
|
| Macromolecular Substances | 2 | 1995 | 1435 | 0.050 |
Why?
|
| Glutamine | 2 | 2008 | 577 | 0.050 |
Why?
|
| Fatty Acid Transport Proteins | 1 | 2002 | 31 | 0.050 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 1027 | 0.050 |
Why?
|
| Visual Field Tests | 2 | 2006 | 415 | 0.050 |
Why?
|
| Psoriasis | 1 | 2010 | 926 | 0.050 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2023 | 143 | 0.050 |
Why?
|
| Antibodies | 1 | 2010 | 2421 | 0.050 |
Why?
|
| Gene Library | 2 | 2002 | 1065 | 0.050 |
Why?
|
| Vitamin E | 1 | 2006 | 874 | 0.050 |
Why?
|
| Eye Enucleation | 2 | 2006 | 128 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 930 | 0.050 |
Why?
|
| Environment | 1 | 2008 | 1121 | 0.050 |
Why?
|
| Genomic Library | 1 | 2002 | 189 | 0.050 |
Why?
|
| Glycine | 2 | 2008 | 672 | 0.050 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2008 | 951 | 0.050 |
Why?
|
| Leucine Zippers | 1 | 2002 | 116 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2004 | 2906 | 0.050 |
Why?
|
| Cysteine | 1 | 2006 | 897 | 0.050 |
Why?
|
| Uvea | 2 | 1978 | 31 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 1986 | 594 | 0.050 |
Why?
|
| Optic Disk | 1 | 2006 | 421 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2004 | 699 | 0.050 |
Why?
|
| DNA, Single-Stranded | 2 | 1993 | 351 | 0.050 |
Why?
|
| Carcinoma | 2 | 1992 | 2330 | 0.050 |
Why?
|
| Protein Conformation | 2 | 2004 | 3956 | 0.050 |
Why?
|
| Confidence Intervals | 1 | 2007 | 2923 | 0.050 |
Why?
|
| Vitamins | 2 | 2006 | 1638 | 0.050 |
Why?
|
| Sarcoidosis | 1 | 2006 | 535 | 0.050 |
Why?
|
| Risk Factors | 7 | 2017 | 74936 | 0.050 |
Why?
|
| Mice, Mutant Strains | 3 | 1994 | 1752 | 0.040 |
Why?
|
| Odds Ratio | 2 | 2018 | 9666 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2006 | 6611 | 0.040 |
Why?
|
| Autopsy | 2 | 2021 | 1011 | 0.040 |
Why?
|
| Vitrectomy | 3 | 2003 | 392 | 0.040 |
Why?
|
| Ophthalmoscopy | 2 | 2008 | 172 | 0.040 |
Why?
|
| Uterine Hemorrhage | 1 | 2002 | 236 | 0.040 |
Why?
|
| Geographic Atrophy | 1 | 2021 | 92 | 0.040 |
Why?
|
| GTP-Binding Proteins | 2 | 2003 | 948 | 0.040 |
Why?
|
| Oligonucleotide Probes | 2 | 1991 | 416 | 0.040 |
Why?
|
| Karyotyping | 6 | 1990 | 1176 | 0.040 |
Why?
|
| Docosahexaenoic Acids | 1 | 2006 | 914 | 0.040 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 2002 | 192 | 0.040 |
Why?
|
| Mice, Transgenic | 4 | 1998 | 9556 | 0.040 |
Why?
|
| Prognosis | 1 | 2020 | 29979 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1991 | 1550 | 0.040 |
Why?
|
| Oxygen | 2 | 2001 | 4269 | 0.040 |
Why?
|
| Injections, Intraocular | 1 | 2018 | 36 | 0.040 |
Why?
|
| Consanguinity | 2 | 2008 | 460 | 0.040 |
Why?
|
| Laminin | 1 | 2000 | 405 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 2 | 2008 | 3771 | 0.040 |
Why?
|
| Apocrine Glands | 1 | 2018 | 31 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 425 | 0.040 |
Why?
|
| Cysteinyldopa | 1 | 1977 | 1 | 0.040 |
Why?
|
| Child, Preschool | 10 | 2007 | 42665 | 0.040 |
Why?
|
| cis-trans-Isomerases | 1 | 1998 | 45 | 0.040 |
Why?
|
| Eccrine Glands | 1 | 2018 | 52 | 0.040 |
Why?
|
| Dihydroxyphenylalanine | 1 | 1977 | 74 | 0.040 |
Why?
|
| Inflammation | 1 | 2018 | 10871 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 1991 | 8637 | 0.040 |
Why?
|
| New England | 1 | 2001 | 1058 | 0.040 |
Why?
|
| Thymidine Kinase | 2 | 1990 | 286 | 0.040 |
Why?
|
| Sympathetic Nervous System | 1 | 1980 | 521 | 0.040 |
Why?
|
| Hyperplasia | 1 | 2001 | 1151 | 0.040 |
Why?
|
| Chloride Channels | 1 | 1999 | 221 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1999 | 451 | 0.040 |
Why?
|
| Recoverin | 1 | 1997 | 11 | 0.040 |
Why?
|
| Hippocalcin | 1 | 1997 | 7 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 2018 | 411 | 0.040 |
Why?
|
| Paternal Age | 1 | 1997 | 87 | 0.040 |
Why?
|
| Epidermal Growth Factor | 1 | 2000 | 697 | 0.040 |
Why?
|
| Lacrimal Apparatus Diseases | 2 | 1992 | 72 | 0.030 |
Why?
|
| Tonometry, Ocular | 1 | 2018 | 238 | 0.030 |
Why?
|
| Adaptation, Physiological | 1 | 2004 | 1311 | 0.030 |
Why?
|
| Melanins | 1 | 1979 | 292 | 0.030 |
Why?
|
| Nuclear Family | 1 | 1998 | 311 | 0.030 |
Why?
|
| Medicare Part B | 1 | 2018 | 116 | 0.030 |
Why?
|
| Leukocytes | 2 | 1998 | 2035 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2008 | 3858 | 0.030 |
Why?
|
| Sensory Thresholds | 3 | 2008 | 377 | 0.030 |
Why?
|
| Carcinoma, Adenoid Cystic | 3 | 1992 | 263 | 0.030 |
Why?
|
| Prostheses and Implants | 1 | 2003 | 1276 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2002 | 1752 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 20218 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2012 | 3463 | 0.030 |
Why?
|
| Complement C3 | 1 | 2018 | 434 | 0.030 |
Why?
|
| Half-Life | 1 | 2017 | 651 | 0.030 |
Why?
|
| Histones | 1 | 2006 | 2600 | 0.030 |
Why?
|
| Cell Survival | 1 | 2005 | 5772 | 0.030 |
Why?
|
| Endothelin-1 | 1 | 2017 | 296 | 0.030 |
Why?
|
| Cataract | 1 | 2002 | 837 | 0.030 |
Why?
|
| Computer-Aided Design | 1 | 2017 | 294 | 0.030 |
Why?
|
| Hair | 1 | 1979 | 508 | 0.030 |
Why?
|
| Blotting, Western | 2 | 2018 | 5024 | 0.030 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2010 | 3781 | 0.030 |
Why?
|
| Chromosome Disorders | 2 | 1991 | 498 | 0.030 |
Why?
|
| Macaca fascicularis | 1 | 2017 | 912 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1996 | 943 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2004 | 1683 | 0.030 |
Why?
|
| Signal Transduction | 2 | 1995 | 23642 | 0.030 |
Why?
|
| Fathers | 1 | 1997 | 377 | 0.030 |
Why?
|
| Menarche | 1 | 1977 | 538 | 0.030 |
Why?
|
| Down-Regulation | 1 | 2001 | 2936 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1995 | 386 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2018 | 588 | 0.030 |
Why?
|
| Choroid Diseases | 1 | 1994 | 63 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 4 | 2008 | 2957 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2008 | 22287 | 0.030 |
Why?
|
| Mitosis | 1 | 1999 | 1177 | 0.030 |
Why?
|
| Retinal Dysplasia | 1 | 1993 | 12 | 0.030 |
Why?
|
| Axons | 1 | 2001 | 1677 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2004 | 5402 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1994 | 310 | 0.030 |
Why?
|
| Mutagenesis | 1 | 1997 | 1228 | 0.030 |
Why?
|
| Poly A | 1 | 1993 | 180 | 0.030 |
Why?
|
| DNA, Recombinant | 2 | 1984 | 455 | 0.030 |
Why?
|
| Cell Division | 1 | 2001 | 4473 | 0.030 |
Why?
|
| Insurance Claim Review | 1 | 2018 | 743 | 0.030 |
Why?
|
| Genes, Regulator | 1 | 1994 | 373 | 0.030 |
Why?
|
| Iron | 1 | 2001 | 1813 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2006 | 6004 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 1991 | 418 | 0.030 |
Why?
|
| Conserved Sequence | 1 | 1996 | 1162 | 0.030 |
Why?
|
| United States | 4 | 2019 | 73027 | 0.030 |
Why?
|
| Gene Amplification | 2 | 1989 | 1088 | 0.030 |
Why?
|
| Young Adult | 3 | 2015 | 60048 | 0.030 |
Why?
|
| Apoptosis | 1 | 2009 | 9521 | 0.030 |
Why?
|
| Calcium | 2 | 2004 | 5794 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2001 | 4146 | 0.030 |
Why?
|
| Dog Diseases | 1 | 1993 | 143 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1997 | 1494 | 0.030 |
Why?
|
| Adenoviruses, Human | 1 | 1994 | 257 | 0.020 |
Why?
|
| Biopsy | 2 | 2019 | 6786 | 0.020 |
Why?
|
| Reference Values | 1 | 1999 | 4938 | 0.020 |
Why?
|
| Activating Transcription Factors | 1 | 1991 | 30 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1994 | 1625 | 0.020 |
Why?
|
| RNA Splicing | 1 | 1995 | 905 | 0.020 |
Why?
|
| Choroideremia | 1 | 1990 | 27 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 1996 | 1972 | 0.020 |
Why?
|
| Rats | 3 | 2002 | 23751 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 2219 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1993 | 899 | 0.020 |
Why?
|
| Antihypertensive Agents | 1 | 2019 | 2029 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2006 | 10396 | 0.020 |
Why?
|
| Adenovirus Early Proteins | 1 | 1989 | 58 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2001 | 3443 | 0.020 |
Why?
|
| Cohort Studies | 4 | 2010 | 41749 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1999 | 1437 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 1995 | 3587 | 0.020 |
Why?
|
| Equipment Design | 1 | 2017 | 3522 | 0.020 |
Why?
|
| Isocitrates | 1 | 2008 | 23 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 1994 | 1207 | 0.020 |
Why?
|
| Oligonucleotides, Antisense | 1 | 1991 | 462 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 1990 | 322 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1995 | 2510 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 6517 | 0.020 |
Why?
|
| Hypopigmentation | 1 | 2008 | 43 | 0.020 |
Why?
|
| Lymphocytes | 3 | 2008 | 2614 | 0.020 |
Why?
|
| Methylation | 1 | 1991 | 1078 | 0.020 |
Why?
|
| Dogs | 1 | 1993 | 3844 | 0.020 |
Why?
|
| Antigens, Polyomavirus Transforming | 1 | 1989 | 256 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 1988 | 190 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 2002 | 5799 | 0.020 |
Why?
|
| Models, Genetic | 1 | 1997 | 3447 | 0.020 |
Why?
|
| NADP | 1 | 2008 | 229 | 0.020 |
Why?
|
| Age Factors | 2 | 2001 | 18407 | 0.020 |
Why?
|
| Oncogene Proteins, Viral | 1 | 1989 | 342 | 0.020 |
Why?
|
| Neuropeptides | 1 | 1993 | 951 | 0.020 |
Why?
|
| Swine | 1 | 2017 | 5994 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2019 | 2913 | 0.020 |
Why?
|
| Infant | 8 | 2001 | 36534 | 0.020 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 2055 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2017 | 2028 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 1992 | 864 | 0.020 |
Why?
|
| Tryptophan | 1 | 2008 | 482 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2019 | 3108 | 0.020 |
Why?
|
| Plasmids | 2 | 1989 | 2269 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 1991 | 1141 | 0.020 |
Why?
|
| Placebos | 1 | 2010 | 1667 | 0.020 |
Why?
|
| Glucocorticoids | 2 | 2006 | 2166 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1995 | 6515 | 0.020 |
Why?
|
| Time Factors | 2 | 2007 | 40214 | 0.020 |
Why?
|
| Germ Cells | 1 | 1989 | 644 | 0.020 |
Why?
|
| Genetic Techniques | 1 | 1988 | 427 | 0.020 |
Why?
|
| Disease Susceptibility | 2 | 1989 | 1793 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2010 | 1715 | 0.020 |
Why?
|
| Guanylate Cyclase-Activating Proteins | 1 | 2004 | 3 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9536 | 0.020 |
Why?
|
| Arginine | 1 | 2008 | 932 | 0.010 |
Why?
|
| Androstadienes | 1 | 2006 | 348 | 0.010 |
Why?
|
| Computational Biology | 2 | 2010 | 3568 | 0.010 |
Why?
|
| Middle East | 1 | 2005 | 233 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2006 | 703 | 0.010 |
Why?
|
| Eye Color | 1 | 2004 | 35 | 0.010 |
Why?
|
| Cricetinae | 2 | 1991 | 2423 | 0.010 |
Why?
|
| Albinism | 1 | 1984 | 25 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1994 | 3402 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 1990 | 3435 | 0.010 |
Why?
|
| Ultraviolet Rays | 3 | 1990 | 1104 | 0.010 |
Why?
|
| Phosphorylation | 1 | 1995 | 8314 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2001 | 5520 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 285 | 0.010 |
Why?
|
| Necrosis | 2 | 2003 | 1616 | 0.010 |
Why?
|
| Species Specificity | 2 | 2002 | 2415 | 0.010 |
Why?
|
| Demography | 1 | 2008 | 1641 | 0.010 |
Why?
|
| Vision Tests | 1 | 1984 | 160 | 0.010 |
Why?
|
| DNA Methylation | 1 | 1997 | 4426 | 0.010 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2007 | 572 | 0.010 |
Why?
|
| Protein Binding | 1 | 1995 | 9343 | 0.010 |
Why?
|
| Polymethyl Methacrylate | 1 | 2003 | 132 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2004 | 695 | 0.010 |
Why?
|
| Sweden | 1 | 2005 | 1382 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2004 | 1731 | 0.010 |
Why?
|
| Fovea Centralis | 1 | 2003 | 126 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 8082 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1991 | 3657 | 0.010 |
Why?
|
| Autoradiography | 1 | 1983 | 727 | 0.010 |
Why?
|
| Occupational Diseases | 2 | 1980 | 1457 | 0.010 |
Why?
|
| Genome, Human | 1 | 1994 | 4443 | 0.010 |
Why?
|
| Trisomy | 1 | 1983 | 260 | 0.010 |
Why?
|
| Infant, Newborn | 3 | 1996 | 26420 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 2006 | 1254 | 0.010 |
Why?
|
| Rodentia | 1 | 1983 | 262 | 0.010 |
Why?
|
| Medicare | 1 | 2019 | 6809 | 0.010 |
Why?
|
| Japan | 1 | 2005 | 1418 | 0.010 |
Why?
|
| Horner Syndrome | 1 | 1980 | 35 | 0.010 |
Why?
|
| Cytological Techniques | 1 | 1982 | 217 | 0.010 |
Why?
|
| Epidemiologic Research Design | 1 | 2004 | 368 | 0.010 |
Why?
|
| Epithelium, Corneal | 1 | 2003 | 247 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1991 | 7612 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1989 | 2881 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2006 | 2596 | 0.010 |
Why?
|
| Pigmentation | 1 | 1980 | 143 | 0.010 |
Why?
|
| Keratitis | 1 | 2003 | 241 | 0.010 |
Why?
|
| Sampling Studies | 1 | 2001 | 615 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 2008 | 39345 | 0.010 |
Why?
|
| Giant Cell Arteritis | 1 | 2004 | 307 | 0.010 |
Why?
|
| HIV Infections | 1 | 2006 | 17569 | 0.010 |
Why?
|
| Chemical Industry | 1 | 1980 | 115 | 0.010 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 2 | 1982 | 498 | 0.010 |
Why?
|
| Conjunctiva | 1 | 2003 | 477 | 0.010 |
Why?
|
| Prednisone | 1 | 2004 | 1567 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2019 | 20757 | 0.010 |
Why?
|
| Forecasting | 1 | 1988 | 2945 | 0.010 |
Why?
|
| Ophthalmia, Sympathetic | 1 | 1979 | 18 | 0.010 |
Why?
|
| Neuroglia | 1 | 1985 | 961 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2019 | 36742 | 0.010 |
Why?
|
| China | 1 | 2005 | 2395 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2008 | 6339 | 0.010 |
Why?
|
| Epithelium | 1 | 2003 | 1607 | 0.010 |
Why?
|
| Electrooculography | 1 | 1998 | 113 | 0.010 |
Why?
|
| Sulfur | 1 | 1979 | 158 | 0.010 |
Why?
|
| Device Removal | 1 | 2003 | 643 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 1999 | 9116 | 0.010 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2006 | 1903 | 0.010 |
Why?
|
| Color | 1 | 1979 | 297 | 0.010 |
Why?
|
| Diterpenes | 1 | 1998 | 169 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2019 | 24314 | 0.010 |
Why?
|
| Corneal Diseases | 1 | 2003 | 535 | 0.010 |
Why?
|
| X-Rays | 2 | 1990 | 311 | 0.010 |
Why?
|
| France | 1 | 1998 | 497 | 0.010 |
Why?
|
| Models, Biological | 1 | 1993 | 9493 | 0.010 |
Why?
|
| Eye Injuries | 1 | 1980 | 228 | 0.010 |
Why?
|
| Educational Status | 1 | 2004 | 2515 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2003 | 2125 | 0.010 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1999 | 646 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 2 | 1994 | 6119 | 0.010 |
Why?
|
| Defective Viruses | 1 | 1994 | 89 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2007 | 10098 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 1999 | 1788 | 0.010 |
Why?
|
| Lac Operon | 1 | 1994 | 237 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1994 | 699 | 0.010 |
Why?
|
| Reoperation | 1 | 2003 | 4329 | 0.010 |
Why?
|
| Methotrexate | 1 | 1999 | 1721 | 0.010 |
Why?
|
| Autoimmune Diseases | 1 | 2004 | 2256 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2002 | 2680 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 4045 | 0.010 |
Why?
|
| Cells, Cultured | 3 | 1998 | 19017 | 0.010 |
Why?
|
| Dopamine | 1 | 1977 | 1592 | 0.010 |
Why?
|
| Genes, Reporter | 1 | 1994 | 1526 | 0.010 |
Why?
|
| Sex Factors | 1 | 2004 | 10627 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 1995 | 3055 | 0.010 |
Why?
|
| Family | 1 | 2000 | 3210 | 0.010 |
Why?
|
| Cricetulus | 1 | 1991 | 812 | 0.010 |
Why?
|
| Mutagens | 1 | 1990 | 181 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2010 | 65364 | 0.010 |
Why?
|
| Genes | 1 | 1991 | 1824 | 0.000 |
Why?
|
| Organelles | 1 | 1989 | 265 | 0.000 |
Why?
|
| Mitomycins | 1 | 1986 | 46 | 0.000 |
Why?
|
| Clone Cells | 1 | 1990 | 1669 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2001 | 14718 | 0.000 |
Why?
|
| Body Mass Index | 1 | 2004 | 13053 | 0.000 |
Why?
|
| Neoplasm Transplantation | 1 | 1989 | 2014 | 0.000 |
Why?
|
| Mitomycin | 1 | 1986 | 261 | 0.000 |
Why?
|
| Epidemiologic Methods | 2 | 1980 | 1326 | 0.000 |
Why?
|
| Mice, Inbred BALB C | 1 | 1994 | 6231 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1989 | 1505 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1984 | 311 | 0.000 |
Why?
|
| Nystagmus, Pathologic | 1 | 1984 | 104 | 0.000 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 1985 | 563 | 0.000 |
Why?
|
| Mice, Nude | 1 | 1989 | 3620 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1990 | 2094 | 0.000 |
Why?
|
| Liver | 1 | 1998 | 7574 | 0.000 |
Why?
|
| Esotropia | 1 | 1984 | 99 | 0.000 |
Why?
|
| Environmental Exposure | 1 | 1977 | 4543 | 0.000 |
Why?
|
| Adenoma, Sweat Gland | 1 | 1982 | 16 | 0.000 |
Why?
|
| Immunoenzyme Techniques | 1 | 1985 | 1698 | 0.000 |
Why?
|
| Cystadenoma | 1 | 1982 | 77 | 0.000 |
Why?
|
| Calcinosis | 1 | 1989 | 1481 | 0.000 |
Why?
|
| West Virginia | 1 | 1980 | 32 | 0.000 |
Why?
|
| Staining and Labeling | 1 | 1984 | 1080 | 0.000 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2004 | 12252 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1989 | 2846 | 0.000 |
Why?
|
| Microspheres | 1 | 1982 | 788 | 0.000 |
Why?
|
| Translocation, Genetic | 1 | 1984 | 1390 | 0.000 |
Why?
|
| Brain | 1 | 2006 | 27366 | 0.000 |
Why?
|
| Cardiovascular Diseases | 1 | 2004 | 15660 | 0.000 |
Why?
|
| Nevus | 1 | 1980 | 205 | 0.000 |
Why?
|
| Astrocytes | 1 | 1985 | 1351 | 0.000 |
Why?
|
| Incidence | 1 | 1995 | 21532 | 0.000 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 1980 | 354 | 0.000 |
Why?
|
| Functional Laterality | 1 | 1983 | 2263 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1984 | 5902 | 0.000 |
Why?
|
| B-Lymphocytes | 1 | 1986 | 4791 | 0.000 |
Why?
|
| Adenoma | 1 | 1982 | 2159 | 0.000 |
Why?
|
| Neoplasm Metastasis | 1 | 1980 | 4904 | 0.000 |
Why?
|